142 filings
Page 3 of 8
8-K
dsy0q4b64e
28 Jun 21
Departure of Directors or Certain Officers
5:02pm
8-K
n3e9zxc yyaa
1 Jun 21
Entry into a Material Definitive Agreement
8:41am
8-K
ihq3q yzw6q
12 May 21
Departure of Directors or Certain Officers
4:21pm
8-K
rr005ohb8
6 May 21
Mirati Therapeutics Reports First Quarter 2021 Financial Results
4:28pm
8-K
tc7 6w9kqy6
30 Mar 21
Departure of Directors or Certain Officers
12:00am
8-K
7uz9gvx
25 Feb 21
Mirati Therapeutics Reports Fourth Quarter and Full-year 2020 Financial Results and Recent Corporate Updates
4:31pm
8-K
3y7 er2lwhkush
11 Jan 21
Regulation FD Disclosure
7:31am
8-K
7vdsdyletp9kaj
4 Nov 20
Mirati Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights
4:36pm
8-K
tjf04jh rm8nz9pje04
28 Oct 20
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
4:38pm
8-K
zb17us6
26 Oct 20
Results of Operations and Financial Condition
4:53pm
8-K
7ynti0 5sd
26 Oct 20
Regulation FD Disclosure
8:00am
8-K
854ub2o3ha336cw1h
6 Aug 20
Mirati Therapeutics Reports Second Quarter 2020 Financial Results and Recent Business Highlights
4:19pm
8-K
3zk2 4pm9cgaklyiox
2 Jul 20
Entry into a Material Definitive Agreement
4:09pm
8-K
j34lcnb wd535m76s
18 May 20
Departure of Directors or Certain Officers
4:43pm
8-K
fnfgm
12 May 20
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
3vtl w5hw4j
7 May 20
Mirati Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Updates
4:18pm
8-K
kcd1 9rbh
25 Feb 20
Mirati Therapeutics Reports Year-end 2019 Financial Results and Recent Corporate Updates
8:21am
8-K
qggo 02t52bq
13 Jan 20
Results of Operations and Financial Condition
6:31am
8-K
0ewwpw3qtwg no
10 Jan 20
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
4:04pm
8-K
9zgakq 6hehpc3c6hcn
6 Jan 20
Mirati Therapeutics Announces Executive Management Changes
4:41pm